high-resolution structure human gpr40 receptor bound allosteric agonist tak- 
human gpr40 receptor hgpr40 also known free fatty-acid receptor ffar1 g-protein-coupled receptor binds long-chain free fatty acids enhance glucose-dependent insulin secretion novel treatments type diabetes mellitus therefore possible targeting hgpr40 partial full agonists tak- fasiglifam orally available potent selective partial agonist hgpr40 receptor reached phase iii clinical trials potential treatment type diabetes mellitus data clinical studies indicate tak- anago-allosteric modulator hgpr40 ref demonstrates improved glycaemic control low hypoglycaemic risk diabetic patients report crystal structure hgpr40 receptor bound tak angstrom resolution co-complex structure reveals unique binding mode tak suggests entry non-canonical binding pocket probably occurs via lipid bilayer atomic details extensive charge network ligand binding pocket reveal additional interactions identified previous studies contribute clear understanding tak binding receptor hgpr40-tak structure also provides insights plausible binding multiple ligands receptor observed radioligand binding ca2+ influx assay studies comparison transmembrane helix architecture g-protein-coupled receptors suggests crystallized tak--bound hgpr40 complex inactive-like state 
